Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$36.4M Buy
103,434
+2,341
+2% +$835K 2.71% 8
2025
Q4
$33.1M Buy
101,093
+575
+0.6% +$182K 2.57% 10
2025
Q3
$28.4M Buy
100,518
+3,438
+4% +$997K 2.27% 12
2025
Q2
$27.1M Buy
97,080
+923
+1% +$261K 2.33% 9
2025
Q1
$30M Buy
96,157
+3,667
+4% +$1.08M 2.63% 7
2024
Q4
$24.1M Buy
92,490
+4,895
+6% +$1.45M 2.2% 12
2024
Q3
$28.2M Buy
87,595
+618
+0.7% +$202K 2.77% 6
2024
Q2
$27.2M Buy
86,977
+2,332
+3% +$685K 2.96% 4
2024
Q1
$24.1M Sell
84,645
-3,210
-4% -$939K 2.68% 7
2023
Q4
$25.3M Sell
87,855
-26
-0% -$7.08K 2.9% 6
2023
Q3
$23.6M Buy
87,881
+1,151
+1% +$287K 2.96% 6
2023
Q2
$19.3M Buy
86,730
+5,201
+6% +$1.21M 2.36% 12
2023
Q1
$19.7M Buy
81,529
+6,631
+9% +$1.63M 2.52% 11
2022
Q4
$19.7M Buy
74,898
+4,015
+6% +$1.08M 2.57% 7
2022
Q3
$16M Buy
70,883
+2,151
+3% +$521K 2.57% 9
2022
Q2
$16.7M Buy
68,732
+756
+1% +$185K 2.56% 8
2022
Q1
$16.4M Buy
67,976
+5,447
+9% +$1.25M 2.28% 13
2021
Q4
$14.1M Buy
62,529
+7,862
+14% +$1.66M 2.01% 16
2021
Q3
$11.9M Buy
54,667
+3,704
+7% +$853K 1.78% 20
2021
Q2
$12.4M Buy
50,963
+132
+0.3% +$32.5K 1.96% 16
2021
Q1
$12.1M Buy
50,831
+8,344
+20% +$1.99M 1.96% 16
2020
Q4
$10.1M Buy
42,487
+8,683
+26% +$2M 1.91% 16
2020
Q3
$8.65M Buy
33,804
+1,178
+4% +$292K 1.9% 16
2020
Q2
$8.16M Buy
32,626
+9,078
+39% +$2.07M 1.94% 16
2020
Q1
$4.77M Sell
23,548
-5,494
-19% -$1.2M 1.35% 37
2019
Q4
$7M Buy
29,042
+325
+1% +$71.6K 1.36% 30
2019
Q3
$5.65M Buy
28,717
+1,155
+4% +$222K 1.2% 34
2019
Q2
$5.08M Buy
27,562
+3,708
+16% +$664K 1.1% 39
2019
Q1
$4.53M Buy
23,854
+2,648
+12% +$506K 1.04% 38
2018
Q4
$4.13M Buy
21,206
+2,419
+13% +$472K 1.1% 37
2018
Q3
$3.89M Buy
18,787
+683
+4% +$135K 0.94% 48
2018
Q2
$3.34M Buy
18,104
+475
+3% +$84K 0.87% 49
2018
Q1
$3M Buy
17,629
+1,435
+9% +$263K 0.81% 50
2017
Q4
$2.82M Buy
16,194
+1,585
+11% +$281K 0.76% 50
2017
Q3
$2.72M Buy
14,609
+524
+4% +$92.8K 0.79% 48
2017
Q2
$2.43M Buy
14,085
+1,890
+15% +$307K 0.74% 50
2017
Q1
$2M Buy
12,195
+3,292
+37% +$547K 0.62% 52
2016
Q4
$1.3M Buy
8,903
+3,350
+60% +$504K 0.45% 61
2016
Q3
$926K Buy
+5,553
New +$939K 0.34% 66

Other funds holding AMGN

Verity & Verity's AMGN Position: Q1 2026 in Review

Verity & Verity increased its Amgen (AMGN) stake by 2.3% in Q1 2026, buying an estimated $835K and bringing the position to 103,434 shares worth $36.4M. The position accounts for 2.71% of the portfolio, ranked #8.

Verity & Verity first reported a position in AMGN in Q3 2016 and has held it in 39 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Verity & Verity held 103,434 shares of Amgen worth $36.4M as of Q1 2026.
  • Verity & Verity bought 2,341 Amgen shares in Q1 2026, an estimated $835K.
  • Amgen made up 2.71% of Verity & Verity's portfolio in Q1 2026, its #8 holding.
  • Verity & Verity first reported a position in Amgen in Q3 2016 and has held it in 39 quarters since.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Verity & Verity's 13F filing for Q1 2026, filed 15 Apr 2026.